Skip to main navigation Skip to search Skip to main content

Severe Coxsackie virus B infection in preterm newborns treated with pleconaril

  • Sofia Bauer
  • , Giora Gottesman
  • , Lea Sirota
  • , Ita Litmanovitz
  • , Shay Ashkenazi
  • , Itzhak Levi

Research output: Contribution to journal › Article › peer-review

70 Scopus citations

Abstract

Four preterm newborn infants with severe multisystem Coxsackie virus B infection were treated with an oral suspension of pleconaril (5 mg/kg per day). The patients had myocarditis, fulminant hepatitis, meningoencephalitis and disseminated intravascular coagulopathy. All four infants recovered, and no adverse effects of the treatment were noted. Conclusion: pleconaril needs to be comprehensively evaluated in this population.

Original languageEnglish
Pages (from-to)491-493
Number of pages3
JournalEuropean Journal of Pediatrics
Volume161
Issue number9
DOIs
StatePublished - 23 Sep 2002
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Coxsackie virus
  • Enterovirus
  • Neonate
  • Pleconaril

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Severe Coxsackie virus B infection in preterm newborns treated with pleconaril'. Together they form a unique fingerprint.

Cite this